Literature DB >> 25143326

Hypokalemia correlated with arterial stiffness but not microvascular endothelial function in patients with primary aldosteronism.

Yi-Yao Chang1, Aaron Chen2, Ying-Hsien Chen3, Chi-Sheng Hung3, Vin-Cent Wu3, Xue-Ming Wu4, Yen-Hung Lin5, Yi-Lwun Ho3, Kwan-Dun Wu3.   

Abstract

INTRODUCTION: Hypokalemia in primary aldosteronism (PA) patients correlates with higher levels of cardiovascular events and altered left ventricular geometry. However, the influence of aldosterone on microvascular endothelial function and the effect of hypokalemia on the vascular structure still remain unclear.
OBJECTIVES: We investigated the peripheral arterial functions, including the endothelial function of microvasculature and arterial stiffness in PA and essential hypertension (EH) patients, and the correlation between hypokalemia and peripheral arterial function among PA patients.
METHODS: Twenty patients diagnosed as EH and 37 patients with PA were enrolled in this study. Reactive hyperemia index (RHI) and the augmentation index (AI) were obtained by non-invasive peripheral arterial tonometry.
RESULTS: Twenty EH patients and a total of 37 PA patients, including 21 patients with normokalemia and 16 patients with hypokalemia, were enrolled and divided into groups 1, 2 and 3 respectively. PA patients had significantly higher AI (p=0.024) but not RHI than EH patients. RHI showed no difference between groups 1, 2 and 3. Group 3 had higher AI than either group 1 or group 2. In the whole study population, serum potassium level, after multivariate regression analysis testing, was the only factor associated with AI (ß= -0.102; p=0.002). In PA patients, serum potassium level was the only significant factor correlated with AI. (r= -0.458; p=0.004)
CONCLUSIONS: PA patients had higher arterial stiffness but comparable microvascular endothelial function to EH patients. Hypokalemia correlated with arterial stiffness but not microvascular endothelial function in PA patients.
© The Author(s) 2014.

Entities:  

Keywords:  Primary aldosteronism; arterial stiffness; augmentation index; hypokalemia; peripheral arterial tonometry

Mesh:

Year:  2014        PMID: 25143326     DOI: 10.1177/1470320314524996

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  4 in total

1.  Cardiovascular risk in primary aldosteronism: A systematic review and meta-analysis.

Authors:  Xueyi Wu; Jie Yu; Haoming Tian
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

Review 2.  Endothelial Dysfunction in Primary Aldosteronism.

Authors:  Zheng-Wei Chen; Cheng-Hsuan Tsai; Chien-Ting Pan; Chia-Hung Chou; Che-Wei Liao; Chi-Sheng Hung; Vin-Cent Wu; Yen-Hung Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

3.  Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change.

Authors:  Sudeep R Aryal; Mohammed Siddiqui; Oleg F Sharifov; Megan D Coffin; Bin Zhang; Krishna K Gaddam; Himanshu Gupta; Thomas S Denney; Louis J Dell'Italia; Suzanne Oparil; David A Calhoun; Steven G Lloyd
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 5.501

4.  Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension.

Authors:  Miaomiao Sang; Yu Fu; Chenmin Wei; Jing Yang; Xueting Qiu; Jingqing Ma; Chao Qin; Feiyan Wu; Xueling Zhou; Tao Yang; Min Sun
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021 Jan-Dec       Impact factor: 1.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.